Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. (Q45360519)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 April 2012

Language	Label	Description	Also known as
English	Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.	scientific article published on 18 April 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Florian van Bömmel

13

object named as

Florian van Bömmel

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

5

object named as

Heiko Witt

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Janett Fischer

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stephan Böhm

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Markus Scholz

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Tobias Müller

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jacob George

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Christoph Sarrazin

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Simone Susser

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Eckart Schott

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

David R Booth

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Graeme J Stewart

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Annika Brodzinski

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Balazs Fülöp

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

18 April 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

55

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1700-1710

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22234924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Expert opinion on the treatment of patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Host genetic determinants of spontaneous hepatitis C clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Human interferon-lambda3 is a potent member of the type III interferon family.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Type III IFNs: new layers of complexity in innate antiviral immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

IL28B and the control of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

IL28B single nucleotide polymorphisms in the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

The role of genetic markers in hepatitis C virus therapy: a major step for individualized care

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

21 January 2018

A new standard of care for the treatment of chronic HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45360519&oldid=2032511122"